News | Cardiac Diagnostics | August 03, 2017

New Study Focuses on Protein Responsible For Increased Heart Disease Risk

Baylor clinical trial will evaluate potential treatment to reduce lipoprotein(a) levels in the bloodstream

New Study Focuses on Protein Responsible For Increased Heart Disease Risk

August 3, 2017 — A study to reduce the strongest inherited risk factor for heart attack and stroke is now underway at Baylor College of Medicine and other sites across the country and Canada.  

Heart specialists at Baylor say the protein lipoprotein(a), known as Lp(a), has been shown to not only be associated with a higher risk of cardiovascular issues but also to be the cause.

“As high levels of Lp(a) travel through the bloodstream, it collects in the arteries, leading to gradual narrowing of the artery that can limit blood supply to parts of the body including the heart and brain,” said Christie Ballantyne, M.D., professor of medicine and chief of the section of cardiology at Baylor. “It can increase the risk of blood clots, heart attack or stroke and affects 2 to 3 percent of the population, which is about 6 to 10 million Americans.”

While there is a simple blood test to check Lp(a) levels, the challenge is that there are no approved treatments that directly target Lp(a).

The current clinical trial is evaluating a potential treatment to reduce plasma Lp(a) levels in patients with hyperlipoprteinemia(a) and established cardiovascular disease. It is a randomized, double-blind, placebo-controlled study, meaning participants and researchers are not aware of who is receiving the treatment. There also will be a placebo group that is not receiving the treatment although five out of six patients randomized will receive the drug at some dose. Baseline levels will be recorded before, during and at determined intervals to compare group results.

“The goal is to test a therapy that targets messenger RNA, which in turn prevents Lp(a) from being produced at such high levels. So it will block the protein from being made,” Ballentyne said.

“It is still important to talk to your doctor about Lp(a) levels. Until a therapy has been approved the most important part of knowing this number, along with your other risk factors, is understanding your overall risk. Your doctor can help you find the right lifestyle modifications or medications to target the other traditional risk factors such as smoking, diabetes, high cholesterol and blood pressure and family history.”

Those risk factors become even more important to monitor when your Lp(a) levels are high, Ballentyne added.

For more information:

Related Content

Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics | December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
New Study Suggests Protein Could Protect Against Coronary Artery Disease

Patients with no obstructed blood flow in the coronary arteries had higher levels of CXCL5 (blue) compared to patients with moderate levels (green) or lower levels (yellow) of CXCL5, who had increased severity of coronary obstructions (indicated by the arrows). Credit: Schisler lab

News | Cardiac Diagnostics | December 07, 2017
December 7, 2017 — The buildup of plaque in the heart’s arteries is an unfortunate part of aging.
E-cigarettes Most Likely to be Used by Alcohol Drinkers and Former Cigarette Smokers, at American Heart Association (AHA), #AHA2017.
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Electronic cigarettes are more frequently used by people who recently quit smoking and alcohol dri
Lack of sleep may cause heart disease in older women. American heart Association, #AHA2017
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Older women who do not get enough sleep were more likely to have poor cardiovascular health, accor
New Tool Predicts Risk of Heart Attack in Older Surgery Patients
News | Cardiac Diagnostics | December 05, 2017
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery...
EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

The EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

News | Cardiac Diagnostics | November 24, 2017
November 24, 2017 — Any physical activity in the elderly is better than none at all for reducing cardiovascular risk,
Analytics 4 Life Presents Clinical Data on Machine-Learned Cardiac Imaging Technology at TCT 2017
News | Cardiac Diagnostics | November 01, 2017
Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary Artery Disease...
American Heart Association, Verily and AstraZeneca Launch One Brave Idea Science Innovation Center
News | Cardiac Diagnostics | October 20, 2017
The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea Science Innovation...
Overlay Init